Introduction: The incomplete immune recovery upon effective long-term highly active antiretroviral therapy (HAART) has been associated with increased morbidity and mortality in HIV infected patients [1]. Immune cellular activation, Tregs or very low-level viraemia has been alternatively suspected, but never investigated simultaneously [2]. Materials and Methods: We performed a cross-sectional study in 87 aviraemic patients (men=62, mean CD4+T cells=570/mm3, mean duration of HAART=12 years). Patients with at least 500 CD4+ T cells /mm3 were classified as complete immunological responders (cIR), whereas remaining patients were classified as inadequate immunological responder (iIR). Tregs were characterized based on CD4+CD25highFoxP3+phenotype...
<div><p>CD4<sup>+</sup> regulatory T cells (Tregs) are essential for the maintenance of the immune s...
HAART in HIV-1-infected individuals has a broad spectrum of clinical outcomes. In the majority of pa...
The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...
Introduction: The incomplete immune recovery upon effective long-term highly active antiretroviral t...
International audienceThe mechanisms sustaining the absence of complete immune recovery in HIV-infec...
BACKGROUND: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia ...
Decades of studies in antiretroviral therapy (ART) have passed, and the mechanisms that determine im...
OBJECTIVE:: Inadequate CD4 cell count recovery despite full HIV RNA control occurs in 30% of HAART-t...
We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...
HIV-infected individuals maintaining undetectable viremia in the absence of therapy (HIV controllers...
BackgroundWhile persistent T-cell activation has been cross-sectionally associated with poor CD4+ T-...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
Background: Low-level HIV viremia originating from virus reactivation in HIV reservoirs is often pre...
We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...
<div><p>Background</p><p>Successful highly active antiretroviral therapy (HAART) has changed the out...
<div><p>CD4<sup>+</sup> regulatory T cells (Tregs) are essential for the maintenance of the immune s...
HAART in HIV-1-infected individuals has a broad spectrum of clinical outcomes. In the majority of pa...
The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...
Introduction: The incomplete immune recovery upon effective long-term highly active antiretroviral t...
International audienceThe mechanisms sustaining the absence of complete immune recovery in HIV-infec...
BACKGROUND: Persistently reduced CD4(+) T-lymphocyte counts in the face of undetectable HIV viremia ...
Decades of studies in antiretroviral therapy (ART) have passed, and the mechanisms that determine im...
OBJECTIVE:: Inadequate CD4 cell count recovery despite full HIV RNA control occurs in 30% of HAART-t...
We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...
HIV-infected individuals maintaining undetectable viremia in the absence of therapy (HIV controllers...
BackgroundWhile persistent T-cell activation has been cross-sectionally associated with poor CD4+ T-...
© 2011 Wolters Kluwer Health | Lippincott Williams & WilkinsObjective: The dynamics of CD4+ regulato...
Background: Low-level HIV viremia originating from virus reactivation in HIV reservoirs is often pre...
We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active anti...
<div><p>Background</p><p>Successful highly active antiretroviral therapy (HAART) has changed the out...
<div><p>CD4<sup>+</sup> regulatory T cells (Tregs) are essential for the maintenance of the immune s...
HAART in HIV-1-infected individuals has a broad spectrum of clinical outcomes. In the majority of pa...
The very first HIV-1 infected patients who received antiretroviral combination therapy (HAART) were ...